Colorectal Cancer
Colorectal cancer can be treated with irinotecan, oxaliplatin and raltitrexed
Published in Cancer Weekly, April 4th, 2006
According to recent research from Canada, "Thirty-one patients with metastatic colorectal cancer were enrolled in this phase I/II trial of a triple combination of C, O, and T, all given on day 1 of a convenient 3-week schedule. Patients received 257 cycles (1-18) in 5 cohorts."
"Toxicity was manageable and haematological toxicity was mild to moderate," explained J.A. Maroun and colleagues, Ottawa Hospital. "Diarrhoea was the main dose-limiting toxicity; nausea and vomiting were common. Fatigue was frequent, moderate in severity and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-04-04)
More Articles from Cancer Weekly
- Cancer Therapy
Arctigenin identified as an antitumor agent - Environmental Health
Cancer incidence linked to air emissions of volatile organic compounds - Melanoma
Spitzoid melanoma identified as distinct subtype of melanoma - Non-Hodgkin Lymphoma
Detection of bone marrow lesions improved by ferumoxtran-10-enhanced MR imaging - Ovarian Cancer
Outcomes after ovarian cancer resection not linked to hospital and surgeon procedure volumes - Acute Myeloid Leukemia
Acute myeloid leukemia risk associated with treatments for Hodgkin lymphoma estimated - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
